The Current Analyst Recommendations for Exact Sciences Corporation (EXAS), CytRx Corporation (CYTR)

Mae Love
September 22, 2017

After a recent check, it is observed that the insiders for the firm now own 2.10% shares.

Exact Sciences Corporation is a molecular diagnostics company. The company has market cap of $5.17 billion. It was reported on Sep, 21 by If the $47.83 price target is reached, the company will be worth $372.40 million more. Beaufort Securities maintained the stock with "Buy" rating in Wednesday, November 30 report. Therefore 63% are positive. Petrofac Ltd had 219 analyst reports since July 23, 2015 according to SRatingsIntel. The rating was maintained by Leerink Swann on Thursday, August 24 with "Buy". The stock of Concho Resources Inc (NYSE:CXO) has "Market Perform" rating given on Friday, December 16 by Wells Fargo. The firm has "Buy" rating given on Tuesday, November 29 by Investec. The rating was maintained by Barclays Capital with "Overweight" on Thursday, August 31. Canaccord Genuity maintained the stock with "Buy" rating in Thursday, September 7 report.

Petrofac Limited is a service provider to the gas and oil production and processing industry. The firm's market capitalization is $5.17 billion. The Firm creates and manufactures gas and oil facilities; operates, maintains and manages facilities and trains personnel; enhances production, and develops and co-invests in upstream and infrastructure projects. It has a 30.05 P/E ratio. The NASDAQ listed company saw a recent bid of $44.74 and 624681 shares have traded hands in the session. It is down 9.30% since September 21, 2016 and is downtrending. Of the analysts surveyed by Reuters that track CytRx Corporation 0 of them rate its stock a hold.

When getting into the markets, most investors realize that riskier stocks may have an increased potential for higher returns. Its up 0.28, from 0.99 in 2017Q1. Russell Investments Group Ltd. increased its holdings in Exact Sciences Corporation by 113.5% in the 1st quarter. 65 funds opened positions while 62 raised stakes. Farmers Merchants Invs Inc, a Nebraska-based fund reported 225 shares. Outstanding shares refer to a company's stock presently held by all its shareholders, counting share blocks held by institutional shareholders and restricted shares owned by the company's officers and insiders. Hanseatic Mngmt owns 0% invested in EXACT Sciences Corporation (NASDAQ:EXAS) for 31 shares. Lombard Odier Asset Mgmt (Usa) Corporation invested in 120,000 shares or 0.34% of the stock. The value of the total investment in Exact Sciences Corporation went from $96,845,000 to $110,733,000 a change of $13,888,000 for the reporting period. Axa has invested 0.01% in EXACT Sciences Corporation (NASDAQ:EXAS). Primecap Mgmt Ca holds 4.50 million shares or 0.14% of its portfolio.

Health workers begin indefinite strike
Nigerian hospitals face the risk of total shutdown as seriously aggrieved health workers commence an indefinite strike action. Biobelemoye Josiah, who addressed journalists in Ilorin, Kwara State capital said the strike would start today.

India says Rohingya refugees threat to national security
Today, jurist Fali Nariman stood with the Rohingyas as several appeals were heard on the Centre's move to deport the Rohingyas. Dal Khalsa Monday said Government of India (GoI) should shed parochial mindset and legalize Rohingyas refugees' stay in India.

Vivo X20, X20 Plus with FHD+ display and dual rear cameras unveiled
The Vivo X20 and X20 Plus smartphones will go up for pre-order in China on September 25, while sales will start on September 30. The larger X20 Plus is also marginally heavier, courtesy of the bigger battery at 181.5 grams, as compared to the 159 gram X20.

Is CytRx Corporation (NASDAQ:CYTR) Cheap From Peers? The medical research company reported ($0.27) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.37) by $0.10. Trexquant Invest Limited Partnership holds 0.06% or 6,100 shares in its portfolio. M&T Bank Corporation stated it has 0% in EXACT Sciences Corporation (NASDAQ:EXAS). A 1 analysts rate it as either a buy or a strong buy, while 0 believe that investors should either steer clear of (NASDAQ:CYTR) or, if they already own its stock, sell it. Therefore 60% are positive.

Investors may be searching high and low for the secret to attaining success in the markets. Currently, the 200-day MA is sitting at 0.28. Craig Hallum boosted their price target on shares of Exact Sciences Corporation from $35.00 to $41.00 in a report on Friday, July 7th. The company was downgraded on Wednesday, June 21 by Seaport Global. The firm has "Neutral" rating given on Thursday, October 8 by Wedbush. On Friday, August 12 the stock rating was upgraded by FinnCap to "Buy". The stock of EXACT Sciences Corporation (NASDAQ:EXAS) earned "Buy" rating by BTIG Research on Monday, July 17. The stock now has a consensus rating of "Buy" and an average price target of $40.98. Benchmark maintained the shares of EXAS in report on Tuesday, July 21 with "Buy" rating. The correct version of this piece of content can be read at

Since March 31, 2017, it had 0 insider purchases, and 1 insider sale for $36,631 activity.

Other reports by

Discuss This Article